Guggenheim Starts Evolent Health (EVH) at Buy
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.58 +3.85%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Guggenheim analyst Sandy Draper initiates coverage on Evolent Health (NYSE: EVH) with a Buy rating and a price target of $43.00.
For an analyst ratings summary and ratings history on Evolent Health click here. For more ratings news on Evolent Health click here.
Shares of Evolent Health closed at $31.18 yesterday.
You May Also Be Interested In
- Evolent Health (EVH) PT Raised to $6 at JPMorgan
- BMO Capital Starts Bicara Therapeutics Inc (BCAX) at Outperform
- BMO Capital Starts Prime Medicine (PRME) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
